160 related articles for article (PubMed ID: 28052022)
21. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction.
McLean S; Bhattacharya M; Di Guglielmo GM
Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267
[TBL] [Abstract][Full Text] [Related]
22. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
[TBL] [Abstract][Full Text] [Related]
23. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of TbetaRII-B, a variant of the type II TGF-beta receptor, in human chondrocytes.
Parker WL; Finnson KW; Soe-Lin H; Knaus P; Philip A
Osteoarthritis Cartilage; 2007 Apr; 15(4):442-53. PubMed ID: 17175180
[TBL] [Abstract][Full Text] [Related]
25. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
[TBL] [Abstract][Full Text] [Related]
26. The core-aldehyde 9-oxononanoyl cholesterol increases the level of transforming growth factor beta1-specific receptors on promonocytic U937 cell membranes.
Gargiulo S; Gamba P; Sottero B; Biasi F; Chiarpotto E; Serviddio G; Vendemiale G; Poli G; Leonarduzzi G
Aging Cell; 2009 Apr; 8(2):77-87. PubMed ID: 19302374
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
28. Receptor expression modulates the specificity of transforming growth factor-beta signaling pathways.
Murakami M; Kawachi H; Ogawa K; Nishino Y; Funaba M
Genes Cells; 2009 Apr; 14(4):469-82. PubMed ID: 19335617
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.
Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S
Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730
[TBL] [Abstract][Full Text] [Related]
30. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
Luo K; Lodish HF
EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
[TBL] [Abstract][Full Text] [Related]
31. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
32. TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.
Kim YW; Park J; Lee HJ; Lee SY; Kim SJ
Biochem J; 2012 Aug; 445(3):403-11. PubMed ID: 22571197
[TBL] [Abstract][Full Text] [Related]
33. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.
Liu C; Billadeau DD; Abdelhakim H; Leof E; Kaibuchi K; Bernabeu C; Bloom GS; Yang L; Boardman L; Shah VH; Kang N
J Clin Invest; 2013 Mar; 123(3):1138-56. PubMed ID: 23454766
[TBL] [Abstract][Full Text] [Related]
34. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X
Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
37. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
38. TGF-β signaling protects retinal neurons from programmed cell death during the development of the mammalian eye.
Braunger BM; Pielmeier S; Demmer C; Landstorfer V; Kawall D; Abramov N; Leibinger M; Kleiter I; Fischer D; Jägle H; Tamm ER
J Neurosci; 2013 Aug; 33(35):14246-58. PubMed ID: 23986258
[TBL] [Abstract][Full Text] [Related]
39. Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.
Luo K; Lodish HF
EMBO J; 1997 Apr; 16(8):1970-81. PubMed ID: 9155023
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung.
Chen H; Zhuang F; Liu YH; Xu B; Del Moral P; Deng W; Chai Y; Kolb M; Gauldie J; Warburton D; Moses HL; Shi W
Eur Respir J; 2008 Aug; 32(2):285-95. PubMed ID: 18321928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]